# Lee's Pharmaceutical Limited clinical trials: 74 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 74 trials with Lee's Pharmaceutical Limited as lead sponsor, 5 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Lee's Pharmaceutical Limited: 74 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/lees-pharmaceutical-limited

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 74
- Recruiting or not yet: 5
- Read on: November 19, 2026

## Trials

The 25 newest of 74, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 21, 2026 | NCT07887490 | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Anfibatide Injection in Healthy Volunteers | Lee's Pharmaceutical Limited | Phase 1 | Not yet recruiting | Healthy Volunteers | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07887490) |
| August 1, 2025 | NCT07099144 | Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension | Lee's Pharmaceutical Limited | Observational | Recruiting | Pulmonary Hypertension, Hypoxic Respiratory Failure | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07099144) |
| May 1, 2025 | NCT06953453 | A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors | Lee's Pharmaceutical Limited | Phase 1 | Recruiting | Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06953453) |
| June 14, 2024 | NCT06459687 | Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer | Lee's Pharmaceutical Limited | Phase 3 | Recruiting | Cervical Cancer | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06459687) |
| April 18, 2024 | NCT06374485 | Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment | Lee's Pharmaceutical Limited | Phase 1 | Completed | Advanced Hepatocellular Carcinoma | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06374485) |
| December 7, 2023 | NCT06160492 | 5-Aminolevulinic Acid for Photodynamic Diagnosis of Malignant Glioma | Lee's Pharmaceutical Limited | Phase 3 | Recruiting | 5-aminolevulinic Acid, Fluorescence-guided Resection, High-Grade Glioma (WHO III-IV) | 79 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06160492) |
| November 2, 2023 | NCT06114953 | Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients | Lee's Pharmaceutical Limited | Phase 4 | Unknown | Kidney Transplant Immunosuppression | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06114953) |
| April 10, 2023 | NCT05806918 | Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer | Lee's Pharmaceutical Limited | Phase 3 | Unknown | Herpes Zoster | 368 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05806918) |
| September 8, 2022 | NCT05531422 | Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP | Lee's Pharmaceutical Limited | Phase 2 | Completed | Breakthrough Cancer Pain | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05531422) |
| March 24, 2022 | NCT05293704 | An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients | Lee's Pharmaceutical Limited | Phase 4 | Unknown | Kidney Transplant Recipients, BK Virus | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05293704) |
| February 22, 2022 | NCT05249725 | Therapeutic Effect of Isogladine Maleate on Small Intestinal Mucosal Injury Associated With NSAIDS in Population | Lee's Pharmaceutical Limited | Phase 4 | Unknown | NSAIDs-associated Intestinal Mucosal Injury | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05249725) |
| January 14, 2022 | NCT05192291 | Clinical Study Evaluating the Efficacy of Iron Proteinsuccinylate Oral Solution（FERPLEX） in Women With Gynecologic Iron Deficiency Anemia | Lee's Pharmaceutical Limited | Observational | Unknown | Patients With Iron Deficiency Anemia in Gynecology | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05192291) |
| July 29, 2021 | NCT04982692 | A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy | Lee's Pharmaceutical Limited | Phase 3 | Completed | Postmenopausal Vulvovaginal Atrophy | 417 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04982692) |
| July 16, 2021 | NCT04964752 | A Study of the Continuous Glucose Monitoring System for Home Use in Patients With Diabetes | Lee's Pharmaceutical Limited | Not applicable | Unknown | Diabetes | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04964752) |
| May 7, 2021 | NCT04878016 | A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC | Lee's Pharmaceutical Limited | Phase 3 | Completed | Extensive-stage Small-cell Lung Cancer | 498 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04878016) |
| April 19, 2021 | NCT04849260 | Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human... | Lee's Pharmaceutical Limited | Phase 1/2 | Unknown | Local Progression or Metastatic Melanoma With Failed First-line Treatment | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04849260) |
| April 15, 2021 | NCT04846842 | A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer | Lee's Pharmaceutical Limited | Phase 2 | Unknown | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04846842) |
| January 19, 2021 | NCT04713189 | Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain | Lee's Pharmaceutical Limited | Phase 1/2 | Unknown | Breakthrough Cancer Pain | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04713189) |
| November 19, 2020 | NCT04636957 | Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Otic Solution in the Treatment of Acute Otitis Externa | Lee's Pharmaceutical Limited | Phase 3 | Completed | Acute Otitis Externa | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04636957) |
| November 13, 2020 | NCT04627116 | An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers | Lee's Pharmaceutical Limited | Phase 1 | Unknown | Healthy Chinese Volunteers | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04627116) |
| October 29, 2020 | NCT04608786 | A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer | Lee's Pharmaceutical Limited | Phase 1 | Unknown | Biliary Tract Cancer | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04608786) |
| October 27, 2020 | NCT04603846 | A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma | Lee's Pharmaceutical Limited | Phase 1 | Unknown | Advanced Urothelial Carcinoma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04603846) |
| October 1, 2020 | NCT04571489 | A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer | Lee's Pharmaceutical Limited | Phase 2 | Unknown | Pancreatic Cancer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04571489) |
| August 6, 2020 | NCT04501029 | A Study of Gimatecan (ST1481) in Small Cell Lung Cancer | Lee's Pharmaceutical Limited | Phase 2 | Unknown | Small Cell Lung Cancer | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04501029) |
| July 7, 2020 | NCT04460066 | A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma. | Lee's Pharmaceutical Limited | Phase 1/2 | Unknown | Esophageal Cancer | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04460066) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 24 |
| Phase 1/2 | 7 |
| Phase 2 | 8 |
| Phase 2/3 | 4 |
| Phase 3 | 17 |
| Phase 4 | 7 |
| Not applicable | 5 |
| Observational | 2 |

## By status

| Status | Trials |
| --- | --- |
| Unknown | 36 |
| Completed | 31 |
| Recruiting | 4 |
| Suspended | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hypertension | 4 |
| Peripheral Arterial Disease | 3 |
| Depression | 3 |
| Papillomavirus Infections | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Fallopian Tube Neoplasms | 2 |
| Anemia, Iron-Deficiency | 2 |
| Diabetes Mellitus | 2 |
| Small Cell Lung Carcinoma | 2 |
| Uterine Cervical Neoplasms | 2 |
| Acne Vulgaris | 2 |
| Hemoptysis | 1 |
| Acute Pain | 1 |
| Carcinoma, Transitional Cell | 1 |
| Pancreatic Neoplasms | 1 |
| Anorexia | 1 |
| Suicide | 1 |
| Herpes Zoster | 1 |
| Glioma | 1 |
| Osteosarcoma | 1 |
| Psychomotor Agitation | 1 |
| Schizophrenia | 1 |
| Bipolar Disorder | 1 |
| Biliary Tract Neoplasms | 1 |
| ST Elevation Myocardial Infarction | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Chemical plants in the United States](https://specstream.ai/data/businesses/chemical-plants/united-states)
- [Taco restaurants in the United States](https://specstream.ai/data/businesses/taco-restaurants/united-states)
- [Livestock feed and supply stores in the United States](https://specstream.ai/data/businesses/livestock-feed-and-supply-stores/united-states)
- [Court reporters in the United States](https://specstream.ai/data/businesses/court-reporters/united-states)
- [Urgent care clinics in the United States](https://specstream.ai/data/businesses/urgent-care-clinics/united-states)
